What are the common side effects of tenofovir alafenamide fumarate tablets (Vemlidy)?

Tenofovir alafenamide fumarate tablets (Vemlidy/Vemlidy) is a highly selective anti-hepatitis B virus drug, and its safety has been verified in multiple international clinical studies. Although it is generally well tolerated, certain adverse reactions may still occur during the early stages of treatment or during long-term medication. Understanding these side effects is critical for safe medication use by patients and follow-up monitoring by physicians.

From a pharmacological mechanism, Veride blocks virus replication by inhibitingHBV DNA polymerase activity in liver cells. This effect usually does not cause significant damage to other cells in the human body, but because the drug needs to be metabolized by the liver and excreted by the kidneys, it may cause mild metabolic or organ stress reactions in some patients. Common clinical adverse reactions include mild headache, nausea, fatigue, gastric discomfort and slight elevation of aminotransferases. These symptoms are usually transient and patients get better over a few weeks.

For long-term medication users, doctors will regularly monitor kidney function and bone metabolism indicators. Although the systemic exposure of TAF (Viridide) is much lower than that of TDF (Viridide), a very small number of patients may still develop mild abnormalities in renal tubular function, such as a mild decrease in creatinine clearance or an increase in urinary protein. These conditions are mostly reversible changes and can usually return to normal by adjusting the dose or suspending the medication.

Some patients may experience mild liver function fluctuations or temporary increases in ALT during the early stages of taking the drug. This is related to virus clearance and liver cell regeneration response, and generally there is no need to stop treatment. If the patient develops obvious symptoms such as persistent fatigue, jaundice or loss of appetite, liver function should be reviewed promptly to rule out drug reactions or viral reactivation.

In addition, a very small number of individuals may have an allergic reaction to the ingredients of the drug, manifesting as rash, itching, or facial edema. In such cases, the drug must be discontinued and medical attention must be sought immediately. Doctors usually recommend that patients stay adequately hydrated during treatment and avoid concurrent use of nephrotoxic drugs.

Reference materials:https://www.vemlidyhcp.com/